RecruitingPhase 2NCT01631617

Effects of Treatments on Atopic Dermatitis

Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis


Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment

130 participants

Start Date

Sep 18, 2012

Study Type

INTERVENTIONAL

Conditions

Summary

Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number and the type of bacteria on the skin. Objectives: \- To study the effect of eczema treatments on skin bacteria. Eligibility: * Individuals between 2 and 25 years of age who have moderate to severe atopic dermatitis. * Healthy volunteers between 18 and 40 years of age with no history of eczema. Design: * Participants will be screened with a physical exam and medical history. Research samples will be collected. Skin biopsies may also be performed. * All participants will be assigned to one of several study groups. * Healthy volunteers must not have taken antibiotics in the year before the start of the study. * All participants will have regular study visits during their 1-year participation. More research samples will be collected at these visits. * Healthy volunteers may be asked to come in for a one-time follow up after the 1 year mark.


Eligibility

Min Age: 2 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cephalexin, a drug called Doxycycline, and others for people with dermatitis, dermatitis atopic, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTrimethoprim/sulfamethoxazole (TMP/SMZ)

800/160 orally every 12 hours for 14 days

DRUGCephalexin

500 mg orally every 8 hours for 14 days

DRUGDoxycycline

20 mg orally every 12 hours for 56 days or 100 mg orally every 12 hours for 56 days

OTHERSodium hypochlorite

6 % dilute bleach

OTHERPlacebo capsules

Capsule orally every 8 hours daily for 14 days

OTHERPlacebo Sodium hypochlorite

Three times a week for 14 days


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01631617


Related Trials